Correlation Between Painreform and Spruce Biosciences

Can any of the company-specific risk be diversified away by investing in both Painreform and Spruce Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Painreform and Spruce Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Painreform and Spruce Biosciences, you can compare the effects of market volatilities on Painreform and Spruce Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Painreform with a short position of Spruce Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Painreform and Spruce Biosciences.

Diversification Opportunities for Painreform and Spruce Biosciences

-0.39

Correlation Coefficient

Painreform  Spruce Biosciences

Very good diversification

The 3 months correlation between Painreform and Spruce is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Painreform and Spruce Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spruce Biosciences and Painreform is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Painreform are associated (or correlated) with Spruce Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spruce Biosciences has no effect on the direction of Painreform i.e., Painreform and Spruce Biosciences go up and down completely randomly.

Pair Corralation between Painreform and Spruce Biosciences

Given the investment horizon of 90 days Painreform is expected to generate 13.39 times more return on investment than Spruce Biosciences. However, Painreform is 13.39 times more volatile than Spruce Biosciences. It trades about 0.11 of its potential returns per unit of risk. Spruce Biosciences is currently generating about -0.14 per unit of risk. If you would invest  255.00  in Painreform on October 25, 2024 and sell it today you would earn a total of  60.00  from holding Painreform or generate 23.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Painreform  vs.  Spruce Biosciences

Painreform

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Painreform are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical and fundamental indicators, Painreform showed solid returns over the last few months and may actually be approaching a breakup point.

Spruce Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spruce Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Painreform and Spruce Biosciences

The main advantage of trading using opposite Painreform and Spruce Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Painreform position performs unexpectedly, Spruce Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spruce Biosciences will offset losses from the drop in Spruce Biosciences' long position.

The idea behind Painreform and Spruce Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..